CN Patent
CN111630029B — 作为免疫调节剂的化合物及其制备方法和应用
Assigned to Nanjing Hencer Pharmacy Co ltd · Expires 2021-04-30 · 5y expired
What this patent protects
本发明公开了式(Ⅱ)所示化合物及其药效上可接受的盐,以及该化合物作为S1P1激动剂的应用。
USPTO Abstract
本发明公开了式(Ⅱ)所示化合物及其药效上可接受的盐,以及该化合物作为S1P1激动剂的应用。
Drugs covered by this patent
- Mayzent (SIPONIMOD) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.